HDL, heart disease, and the lung.
作者信息
Frey Kathrin, von Eckardstein Arnold
机构信息
University Hospital Zurich and University of Zurich, Institute of Clinical Chemistry, Zurich, Switzerland.
University Hospital Zurich and University of Zurich, Institute of Clinical Chemistry, Zurich, Switzerland.
出版信息
J Lipid Res. 2022 Jun;63(6):100217. doi: 10.1016/j.jlr.2022.100217. Epub 2022 Apr 27.
Abstract
摘要
相似文献
1
HDL, heart disease, and the lung.高密度脂蛋白、心脏病与肺部
J Lipid Res. 2022 Jun;63(6):100217. doi: 10.1016/j.jlr.2022.100217. Epub 2022 Apr 27.
2
HDL cholesterol and risk of heart disease.高密度脂蛋白胆固醇与心脏病风险
Phys Ther. 1984 Nov;64(11):1724, 1729.
3
[Drug clinics. How I treat a patient with a low concentration of HDL cholesterol].[药物诊所。我如何治疗高密度脂蛋白胆固醇浓度低的患者]
Rev Med Liege. 1998 Dec;53(12):727-31.
4
Ratio may foretell risk of heart disease.比率可能预示心脏病风险。
Health News. 2001 Apr;7(4):6.
5
Association of high-density-lipoprotein cholesterol with mortality and other risk factors for major chronic noncommunicable diseases in samples of US and Russian men.美国和俄罗斯男性样本中高密度脂蛋白胆固醇与主要慢性非传染性疾病死亡率及其他风险因素的关联
Ann Epidemiol. 1995 May;5(3):179-85. doi: 10.1016/1047-2797(94)00104-2.
6
Cholesterol conundrum.胆固醇难题。
Sci Am. 2011 Nov;305(5):32-3. doi: 10.1038/scientificamerican1111-32.
7
[How I study a patient with a low concentration of HDL cholesterol].[我如何研究高密度脂蛋白胆固醇浓度低的患者]
Rev Med Liege. 1998 Nov;53(11):711-4.
8
Hemostatic factors and the risk of myocardial infarction.止血因子与心肌梗死风险
N Engl J Med. 1995 Aug 10;333(6):389; author reply 389-90. doi: 10.1056/NEJM199508103330616.
9
Understanding cholesterol and its role in heart disease.了解胆固醇及其在心脏病中的作用。
Nurs Times. 2007;103(2):28-9.
10
High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study.高密度脂蛋白胆固醇作为男性和女性心血管疾病死亡率的预测指标：脂质研究临床患病率研究的随访研究
Am J Epidemiol. 1990 Jan;131(1):32-47. doi: 10.1093/oxfordjournals.aje.a115483.
引用本文的文献
1
[HDL - Quo vadis].[高密度脂蛋白——何去何从]
Dtsch Med Wochenschr. 2023 May;148(10):627-635. doi: 10.1055/a-1516-2731. Epub 2023 Apr 20.
本文引用的文献
1
Pulmonary surfactant protein B carried by HDL predicts incident CVD in patients with type 1 diabetes.高密度脂蛋白携带的肺表面活性物质蛋白B可预测1型糖尿病患者发生心血管疾病的风险。
J Lipid Res. 2022 Apr;63(4):100196. doi: 10.1016/j.jlr.2022.100196. Epub 2022 Mar 14.
2
Gene Therapy Potential for Genetic Disorders of Surfactant Dysfunction.针对表面活性剂功能障碍的遗传性疾病的基因治疗潜力。
Front Genome Ed. 2022 Jan 14;3:785829. doi: 10.3389/fgeed.2021.785829. eCollection 2021.
3
The HDL Proteome Watch: Compilation of studies leads to new insights on HDL function.高密度脂蛋白蛋白质组观察：研究综合分析带来对高密度脂蛋白功能的新认识。
Biochim Biophys Acta Mol Cell Biol Lipids. 2022 Feb;1867(2):159072. doi: 10.1016/j.bbalip.2021.159072. Epub 2021 Nov 18.
4
Reproducible Determination of High-Density Lipoprotein Proteotypes.高密度脂蛋白蛋白类型的可重现性测定。
J Proteome Res. 2021 Nov 5;20(11):4974-4984. doi: 10.1021/acs.jproteome.1c00429. Epub 2021 Oct 22.
5
HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research.21 世纪的高密度脂蛋白：未来高密度脂蛋白研究的多功能路线图。
Circulation. 2021 Jun 8;143(23):2293-2309. doi: 10.1161/CIRCULATIONAHA.120.044221. Epub 2021 Jun 7.
6
Novel Insights From Human Studies on the Role of High-Density Lipoprotein in Mortality and Noncardiovascular Disease.从人类研究中获得的关于高密度脂蛋白在死亡率和非心血管疾病中的作用的新见解。
Arterioscler Thromb Vasc Biol. 2021 Jan;41(1):128-140. doi: 10.1161/ATVBAHA.120.314050. Epub 2020 Nov 24.
7
Structure-function relationships of HDL in diabetes and coronary heart disease.载脂蛋白在糖尿病和冠心病中与高密度脂蛋白的结构-功能关系。
JCI Insight. 2020 Jan 16;5(1):131491. doi: 10.1172/jci.insight.131491.
8
Immature surfactant protein-B impairs the antioxidant capacity of HDL.不成熟的表面活性蛋白-B 会损害 HDL 的抗氧化能力。
Int J Cardiol. 2019 Jun 15;285:53-58. doi: 10.1016/j.ijcard.2019.02.057. Epub 2019 Feb 27.
9
AIBP augments cholesterol efflux from alveolar macrophages to surfactant and reduces acute lung inflammation.AIBP 增强肺泡巨噬细胞向表面活性剂的胆固醇外流，减少急性肺炎症。
JCI Insight. 2018 Aug 23;3(16). doi: 10.1172/jci.insight.120519.
10
Proteomic diversity of high-density lipoprotein explains its association with clinical outcome in patients with heart failure.高密度脂蛋白蛋白质组学的多样性解释了其与心力衰竭患者临床结局的相关性。
Eur J Heart Fail. 2018 Feb;20(2):260-267. doi: 10.1002/ejhf.1101. Epub 2017 Dec 18.
Zotero 插件